LENZ Therapeutics, Inc. (LENZ)
Healthcare • Biotechnology • $3.25 • MCap: 102,744,528
https://www.lenz-tx.com • LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
| Score | Price | 52 Week & Averages | Relative Strength | Risk | |||||
|---|---|---|---|---|---|---|---|---|---|
| Total | 42 | Current | $3.25 | 52W High | $31.97 -89.83% | Relative Strength | -0.64 | Beta | 1.73 |
| Business Quality | 10 | Weekly | $3.57 -8.96% | 52W Low | $3.19 1.88% | 3M | -0.41 | Short % | 0.55 |
| Financial Strength | 11 | Monthly | $4.13 -21.31% | Above 50DMA | $4.25 -23.60% | 6M | -0.64 | Risk Score | 8 |
| Growth Outlook | 1 | Quarterly | $5.48 -40.69% | Above 200DMA | $8.41 -61.35% | 9M | -0.85 | ||
| Momentum | 3 | Yearly | $31.29 -89.61% | 12M | -0.90 | ||||
| Valuation | Financial Strength | Growth/Profitability | |||
|---|---|---|---|---|---|
| Trailing P/E | N/A | Cash | 220M | Revenue Growth | 0.10% |
| Forward P/E | -1.12 | Debt | 1M | Earnings Growth | N/A |
| PEG Ratio | N/A | Debt/Equity | 0.26 | Qtr Earnings Growth | N/A |
| Price/Sales | 4.78 | Current Ratio | 13.55 | Gross Margin | 0.92% |
| Price/Book | 0.47 | Quick Ratio | 12.91 | Operating Margin | -6.23% |
| EV/Revenue | -5.43 | Operating CF | -114M | Profit Margin | 0.00% |
| EV/EBITDA | 0.86 | Free CF | -71M | EBITDA Margin | 0.00% |
| Ent Value | -117M | Return on Assets | -0.37% | ||
| Return on Equity | -0.59% | ||||
| Technical | Volume & Bollinger Bands | Analyst | |||
|---|---|---|---|---|---|
| RSI | 33.86 | Volume | 0.94M | Rating | buy |
| Previous RSI | 32.60 | Avg Volume 20D | 0.77M | Target Mean | $23.86 |
| RSI Trend | Up | Relative Volume | 0.56 | Target High | $60.00 |
| MACD | -0.30 | Lower Band | 3.08 | Target Low | $7.00 |
| MACD Signal | -0.30 | Middle Band | 3.57 | Target Median | $10.00 |
| Histogram | 0.01 | Upper Band | 4.05 | Analysts | 7 |
| Previous Histogram | 0.00 | Bandwidth | 27.190 | Upside | 629.58% |
| Histogram Trend | Increasing | %B | 0.17 | ||
